Regulation of CD47 expression in cancer cells
2020 · Translational Oncology · 117 citations
https://doi.org/10.1016/j.tranon.2020.100862
M
Mu‐Yang Huang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
23
Papers
965
Citations
15
h-index
18
i10-index
Mu‐Yang Huang is an academic researcher from University of Macau. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Phagocytosis and Immune Regulation & Immune Cell Function and Interaction. The author has an h-index of 15, co-authored 20 publications.
Papers by this author
worksAnticancer drug discovery from Chinese medicinal herbs
2018 · Chinese Medicine · 103 citations
https://doi.org/10.1186/s13020-018-0192-y
Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10
2023 · Pharmacological Research · 54 citations
https://doi.org/10.1016/j.phrs.2023.106988
Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives
2022 · Acta Pharmaceutica Sinica B · 34 citations
https://doi.org/10.1016/j.apsb.2022.12.016
c-MYC-mediated TRIB3/P62+ aggresomes accumulation triggers paraptosis upon the combination of everolimus and ginsenoside Rh2
2021 · Acta Pharmaceutica Sinica B · 23 citations
https://doi.org/10.1016/j.apsb.2021.09.014
Identification of Bulbocodin D and C as novel STAT3 inhibitors and their anticancer activities in lung cancer cells
2023 · Chinese Journal of Natural Medicines · 5 citations
https://doi.org/10.1016/s1875-5364(23)60521-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat